{"meta":{"query_hash":"997e5d114ffb","filters":{"venue":"Breast Cancer Online"},"cohort_total":7,"direct_labels_cover":0,"predictions_cover":7,"exported":7,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/997e5d114ffb","api":"https://metacan.xera.ac/api/v1/cohort?venue=Breast+Cancer+Online"},"results":[{"id":"W2072988283","doi":"10.1017/s1470903107006578","title":"Review of:Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma","year":2007,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tamoxifen; Estrogen receptor; Breast cancer; Internal medicine; Confidence interval; Oncology; Breast carcinoma; Medicine; Immunohistochemistry; Estrogen; Estrogen receptor alpha; Adjuvant; Cancer","score_opus":0.006480967054905769,"score_gpt":0.26844400551687664,"score_spread":0.2619630384619709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072988283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006354031,0.9879308,0.00012635208,0.004058763,0.005813064,0.000014507567,0.00015987015,0.00001240084,0.0012488065],"genre_scores_gemma":[0.0045237886,0.9786679,0.00024255455,0.0028976705,0.011530248,0.000026014051,0.00032745284,0.000010412088,0.0017740068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992131,0.00016552347,0.00023155067,0.00017841016,0.00017650709,0.000034863566],"domain_scores_gemma":[0.996274,0.0015868418,0.00046386322,0.00006998407,0.0013954995,0.00020979978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010910934,0.0005391373,0.001712375,0.004000869,0.00034255494,0.0014361085,0.0013280553,0.0015113789,0.004745524],"category_scores_gemma":[0.0034948974,0.00034589975,0.00048308427,0.0045407545,0.00062745356,0.0012563536,0.00048461437,0.001189945,0.002264069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035214415,0.00008409909,0.004462665,0.029770343,0.00025848227,0.00059030135,0.00016331027,0.00016109363,0.001050194,0.00077108515,0.4197885,0.54254776],"study_design_scores_gemma":[0.000053707885,0.00022870793,0.020286426,0.015497195,0.00060355314,0.0076093827,0.000312359,0.00014601363,0.00036827358,0.0005901744,0.95423716,0.00006713166],"about_ca_topic_score_codex":0.0015813103,"about_ca_topic_score_gemma":0.0021934845,"teacher_disagreement_score":0.004745524,"about_ca_system_score_codex":0.00084242516,"about_ca_system_score_gemma":0.0012792326,"threshold_uncertainty_score":0.01587534},"labels":[],"label_agreement":null},{"id":"W2073096001","doi":"10.1017/s1470903106005608","title":"Review of: Methylation of estrogen receptor β promoter correlates with loss of ER-β expression in mammary carcinoma and is an early indication marker in premalignant lesions","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Manitoba","funders":"","keywords":"Methylation; Estrogen receptor; DNA methylation; Cancer research; Breast cancer; Estrogen receptor alpha; Estrogen; Biology; Estrogen receptor beta; Progesterone receptor; Breast carcinoma; Internal medicine; Cancer; Gene expression; Pathology; Endocrinology; Gene; Medicine; Genetics","score_opus":0.00949929170313539,"score_gpt":0.2625247605753156,"score_spread":0.2530254688721802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073096001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036035062,0.97899777,0.00027498673,0.005277163,0.0116521735,0.000016793456,0.00017588024,0.000027400883,0.003217399],"genre_scores_gemma":[0.002396377,0.9771887,0.00032349039,0.002609122,0.013504223,0.000017982875,0.00036736613,0.000014698611,0.0035781348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923265,0.000109714594,0.00016965126,0.00022332076,0.00022021984,0.000044435154],"domain_scores_gemma":[0.9970624,0.0008833073,0.00033339215,0.0000618888,0.0013608775,0.0002980291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095038046,0.0009162116,0.0018861189,0.004511409,0.00043019073,0.0016989545,0.0015861063,0.0018188051,0.010902122],"category_scores_gemma":[0.002976071,0.00044676528,0.0004950719,0.0045173834,0.0008134669,0.0019487122,0.0006658114,0.0021558632,0.0066739754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016076621,0.00006333188,0.0012168584,0.015213056,0.000118269774,0.0006395915,0.00009271607,0.00016240335,0.0011373925,0.0011105104,0.45242402,0.5276611],"study_design_scores_gemma":[0.00002207785,0.00007159311,0.0036614896,0.0031132342,0.0001351482,0.004717678,0.0000967951,0.00006313221,0.00027917308,0.0004446513,0.98736435,0.000030651885],"about_ca_topic_score_codex":0.0017514935,"about_ca_topic_score_gemma":0.001979536,"teacher_disagreement_score":0.010902122,"about_ca_system_score_codex":0.0010150253,"about_ca_system_score_gemma":0.0013955575,"threshold_uncertainty_score":0.036471307},"labels":[],"label_agreement":null},{"id":"W2120895687","doi":"10.1017/s1470903105003718","title":"Fractionation in radiotherapy: results of a Canadian randomised clinical trial","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Fractionation; Limiting; Clinical trial; Dose fractionation; Oncology; Nuclear medicine; Fraction (chemistry); Internal medicine; Cancer; Chemistry","score_opus":0.030814491597210975,"score_gpt":0.35322590289877265,"score_spread":0.3224114113015617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120895687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72214687,0.119426444,0.005501872,0.034892455,0.0061471076,0.039786104,0.020346701,0.0004717438,0.0512808],"genre_scores_gemma":[0.8883575,0.04196393,0.011469375,0.013631805,0.002135735,0.015570349,0.006622123,0.00023749202,0.020011675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9867231,0.008771795,0.0008663633,0.00089627306,0.0015543337,0.0011881244],"domain_scores_gemma":[0.9894839,0.0028335075,0.0021377793,0.00088717433,0.0021366214,0.0025209212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013365236,0.001963963,0.0041107377,0.0009307124,0.0022601031,0.0022404417,0.0018180946,0.003804592,0.009728328],"category_scores_gemma":[0.021909175,0.0007911088,0.0052118343,0.0033718164,0.0022365118,0.0012474712,0.001072126,0.0030857085,0.0010227808],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91691655,0.002611587,0.0021010744,0.0030748518,0.0032575566,0.000097399556,0.00022883015,0.0010763129,0.001003656,0.0012860524,0.010933375,0.05741284],"study_design_scores_gemma":[0.9467732,0.024434574,0.011828683,0.000633559,0.0037172816,0.00005616976,0.00009627984,0.0005656819,0.0002512085,0.0007374625,0.010790361,0.00011564714],"about_ca_topic_score_codex":0.5223914,"about_ca_topic_score_gemma":0.64151365,"teacher_disagreement_score":0.5223914,"about_ca_system_score_codex":0.026018329,"about_ca_system_score_gemma":0.050321624,"threshold_uncertainty_score":0.9608427},"labels":[],"label_agreement":null},{"id":"W2136302397","doi":"10.1017/s1470903105000817","title":"A case study from the Sunnybrook and Women's College Health Sciences Centre: Do clinical trials of neoadjuvant chemotherapy for locally advanced breast cancer (LABC) overestimate the actual response rates observed in clinical practice?","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Medicine; Oncology; Clinical trial; Internal medicine; Chemotherapy; Complete response; Gynecology; Cancer","score_opus":0.08855546023901296,"score_gpt":0.4636427422525191,"score_spread":0.37508728201350616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136302397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584675,0.0051930333,0.0015054143,0.018120075,0.00033385912,0.00069167645,0.00051437196,0.00001947107,0.015154674],"genre_scores_gemma":[0.9847542,0.0030401282,0.0023395144,0.0054168035,0.0004251029,0.00016726933,0.00020314078,0.00003308405,0.0036206942],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.99352324,0.0034900995,0.00060330576,0.00056303345,0.001256993,0.00056329335],"domain_scores_gemma":[0.9682344,0.019823555,0.0051734587,0.0013328916,0.0023764106,0.0030592359],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005486766,0.0006839794,0.00069799786,0.0019580063,0.0052433363,0.0016828977,0.0012419778,0.0047001205,0.0058474764],"category_scores_gemma":[0.031695824,0.0008578737,0.00070210884,0.0022167147,0.0019440241,0.0010331426,0.0013833723,0.0026223063,0.00047337104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018472164,0.0018234353,0.39776623,0.0011605935,0.0002696207,0.51523703,0.0262489,0.0005335342,0.0020605153,0.0038603232,0.02182825,0.02736435],"study_design_scores_gemma":[0.0007700936,0.0037031127,0.18661746,0.0012103604,0.00049154815,0.7066575,0.047707405,0.0011094637,0.0037349944,0.0011895864,0.046579316,0.00022912562],"about_ca_topic_score_codex":0.037209112,"about_ca_topic_score_gemma":0.07493699,"teacher_disagreement_score":0.9945132,"about_ca_system_score_codex":0.0047074854,"about_ca_system_score_gemma":0.0032944977,"threshold_uncertainty_score":0.0739851},"labels":[],"label_agreement":null},{"id":"W2159639385","doi":"10.1017/s1470903108004343","title":"Current status of adjuvant bisphosphonates in operable breast cancer","year":2008,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Adjuvant; Zoledronic acid; Oncology; Breast cancer; Clinical trial; Internal medicine; Adjuvant therapy; Cancer; Stage (stratigraphy)","score_opus":0.02816947140264372,"score_gpt":0.34485234089592753,"score_spread":0.31668286949328384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159639385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002148989,0.98859674,0.0001939536,0.006231695,0.00047772,0.000010161423,0.00010415007,0.000018122404,0.0022185587],"genre_scores_gemma":[0.035269476,0.9554972,0.00081250246,0.004609501,0.0024628732,0.00006633358,0.00038026914,0.000011479634,0.0008904746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894744,0.00031916384,0.00032092677,0.00010340775,0.0002207979,0.0000882914],"domain_scores_gemma":[0.99375004,0.0035893733,0.0010728252,0.00010634672,0.0010107087,0.00047064465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004532959,0.00041533005,0.0012687704,0.0011015969,0.00035704178,0.0020936301,0.0009702204,0.0018935349,0.0046621766],"category_scores_gemma":[0.006572931,0.0002994059,0.000643866,0.0017994273,0.0009538425,0.0021913438,0.00059673644,0.001734596,0.0015049458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017742235,0.0002575545,0.0030684222,0.0076590744,0.000146518,0.00014682446,0.00006705428,0.0005909946,0.0009596192,0.002336883,0.019162703,0.9638302],"study_design_scores_gemma":[0.0010548095,0.004924148,0.017490705,0.017867176,0.0017046581,0.0021137395,0.0005621371,0.0012706826,0.002705772,0.006786209,0.943442,0.000078085584],"about_ca_topic_score_codex":0.0015609441,"about_ca_topic_score_gemma":0.003136967,"teacher_disagreement_score":0.0046621766,"about_ca_system_score_codex":0.0014142347,"about_ca_system_score_gemma":0.002633294,"threshold_uncertainty_score":0.023972869},"labels":[],"label_agreement":null},{"id":"W2163819426","doi":"10.1017/s1470903104002950","title":"Review of: The expression of ER beta cx in human breast cancer and the relationship to endocrine therapy and survival","year":2004,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Endocrine system; Oncology; Action (physics); Breast cancer; Internal medicine; Content (measure theory); Medicine; Cancer; Cancer research; Endocrinology; Hormone; Mathematics; Physics","score_opus":0.014726380836168122,"score_gpt":0.3030234911956493,"score_spread":0.2882971103594812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163819426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034554314,0.98288924,0.00023700675,0.0039762827,0.009162464,0.000010697458,0.00018593614,0.000016852657,0.0031759802],"genre_scores_gemma":[0.0025539307,0.9764498,0.00042835932,0.0025503153,0.012201466,0.000016645607,0.00027492992,0.000010205304,0.005514392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995993,0.000076652,0.00008821641,0.0000736893,0.0001410563,0.000021160957],"domain_scores_gemma":[0.9980465,0.00076552795,0.00024280816,0.000037093643,0.0007395389,0.00016848659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007682237,0.0007275871,0.0013543642,0.0037826945,0.0003282048,0.0011972915,0.0012822676,0.0011992828,0.013153437],"category_scores_gemma":[0.0022691728,0.00020709907,0.00034267464,0.0047914274,0.00055375026,0.0018195923,0.0004658863,0.001196371,0.0069125625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019061507,0.000045844223,0.0008461038,0.012076657,0.00008511641,0.0005365428,0.00006902238,0.00020276467,0.000830368,0.0014069445,0.46501002,0.51870006],"study_design_scores_gemma":[0.000010574757,0.00005832825,0.0025421714,0.0026992026,0.000085849395,0.0025096193,0.000057270983,0.00005055472,0.00016463012,0.00052263745,0.9912854,0.000013645889],"about_ca_topic_score_codex":0.0014393486,"about_ca_topic_score_gemma":0.0020469967,"teacher_disagreement_score":0.013153437,"about_ca_system_score_codex":0.000777977,"about_ca_system_score_gemma":0.00087919063,"threshold_uncertainty_score":0.044002593},"labels":[],"label_agreement":null},{"id":"W4235795553","doi":"10.1017/s1470903106009308","title":"National Cancer Institute of Canada – Clinical Trials Group <b>(NCIC CTG)</b>","year":2006,"lang":"en","type":"article","venue":"Breast Cancer Online","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Letrozole; Antiestrogen; Breast cancer; Tamoxifen; Internal medicine; Oncology; Cancer; Adjuvant therapy; Placebo; Clinical trial; Randomized controlled trial; Gynecology; Pathology","score_opus":0.04653013405971362,"score_gpt":0.3826291117087254,"score_spread":0.33609897764901175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235795553","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021288758,0.029602483,0.003960279,0.023415545,0.009986447,0.03745187,0.20475173,0.0030874792,0.68561536],"genre_scores_gemma":[0.029237598,0.066801436,0.03517002,0.04346058,0.007034927,0.05323537,0.24777639,0.0031942972,0.51408935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896265,0.0036948756,0.001005122,0.0010057837,0.0036742038,0.0009933665],"domain_scores_gemma":[0.9549604,0.0068698376,0.004508173,0.0035807563,0.023045301,0.0070355083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010125685,0.0019446884,0.0038730076,0.002562039,0.0025895294,0.0073605804,0.0040410855,0.0062124454,0.24387145],"category_scores_gemma":[0.03053295,0.0013386314,0.0020267526,0.0076613016,0.0013289384,0.0016471432,0.0012756784,0.0046454007,0.11122329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026556929,0.00016608204,0.0003585327,0.002688993,0.00012353263,0.00003519659,0.000026463951,0.00012489322,0.0005326778,0.0015465064,0.9334931,0.058248214],"study_design_scores_gemma":[0.007707839,0.000520461,0.0050500985,0.002608217,0.00021628283,0.00011084393,0.000039931147,0.0003001693,0.00033256496,0.00083905197,0.98219913,0.000075516655],"about_ca_topic_score_codex":0.20408213,"about_ca_topic_score_gemma":0.47050503,"teacher_disagreement_score":0.24387145,"about_ca_system_score_codex":0.014718431,"about_ca_system_score_gemma":0.07658457,"threshold_uncertainty_score":0.8158313},"labels":[],"label_agreement":null}]}